Dr Hendrik-Tobias Arkenau is Medical Director at Sarah Cannon Research UK in London.
Dr Arkenau received his medical and postgraduate degree at the Medical School Hanover, Germany, and completed his internship and specialist training in oncology in 2007. Before being appointed as, he was Senior Clinical Fellow at the Royal Marsden Hospital and team leader for Early Drug Development at the Prince of Wales Clinical School at the University of New South Wales, Sydney, Australia.
He has obtained ASCO, AACR and ESMO Merit Awards and languages spoken are English and German
